Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioNTech SE ADR buy Ellritze

BioNTech SE ADR
Start price
€131.05
22.01.22 / 70%
Target price
€150.00
22.01.23
Performance (%)
19.38%
End price
€156.45
06.02.22
Summary
This prediction ended on 06.02.22 with a price of €156.45. The prediction had a final performance of 19.38%. Ellritze has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
BioNTech SE ADR 7.896% 7.896% 243.124%
iShares Core DAX® 1.804% -0.748% 13.168%
iShares Nasdaq 100 -0.182% -3.412% 39.976%
iShares Nikkei 225® 0.413% -7.381% 18.776%
iShares S&P 500 0.664% -1.941% 28.141%

According to Ellritze what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
Differentiated customer and product portfolio
Top 10 in its market
Cons
Higher risks for its business
High valuation

Comments by Ellritze for this prediction

In the thread Biontech SE diskutieren
Prediction Buy
Perf. (%) 19.38%
Target price 150.000
Change
Ends at 22.01.23

Buy mit Kursziel 150,0

Ellritze 
0
Report Share
22.01.22
In the thread Trading Biontech SE
Prediction Buy
Perf. (%) 19.38%
Target price 150.000
Change
Ends at 22.01.23

Buy beendet

Ellritze 
0
Report Share
06.02.22

Stopped prediction by Ellritze for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€228.00
25.12.21
€260.00
25.12.22
-15.86%
06.01.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
Ellritze 
25.12.21 70%
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€238.20
12.12.21
€260.00
12.12.22
-4.28%
25.12.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
Ellritze 
12.12.21 70%
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€321.00
28.11.21
€400.00
28.11.22
-25.79%
12.12.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
Ellritze 
28.11.21 70%